Open Date
04 Aug 2023
08 Aug 2023
20 shares
₹1,551 Cr
Lot Size
IPO Size
Listing At
BSE, NSE
Listing Date
Price Range
₹705 to ₹741 per share
Close Date
Allotment Date
11 Aug 2023
18 Aug 2023
Concord Biotech Limited, founded in 1984, is an India-based R&D-driven biopharma firm.They sell their products in over 70 countries, including the United States, India, Europe, and Japan. The company manufactures Active Pharmaceutical Ingredients (API) through fermentation & semi-synthetic process and finished formulations. It started with a single product and has grown to become a wide-spectrum solution provider.
The book-running lead managers to the offer are: Kotak Mahindra Capital Company Ltd Citigroup Global Markets India Private Ltd Jefferies India Private Ltd